Beo Therapeutics ApS: Financial statements 2021
CVR: 39880377
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Beo Therapeutics ApS (CVR 39880377) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK 418 compared with DKK 0 the year before. Equity in the 2021 report amounted to DKK 40,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 418
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
Official annual report
Find more companies like Beo Therapeutics ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
On October 1, 2021, the company changed its name from Beo Therapeutics IVS to Beo Therapeutics ApS.
Beo Therapeutics ApS has published its annual report for 2020. The net result was DKK 0.
About Beo Therapeutics ApS
Beo Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Beo Therapeutics IVS. The management consists of Rikke Christina Nielsen. The company is owned by Rikke Christina Nielsen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 4,985 compared with DKK -4,910 the year before. Equity in the 2025 report amounted to DKK 40,075.